Rockefeller Capital Management’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.58K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $2K | Hold |
|
|||||
|
2022
Q3 | $2K | Hold |
|
|||||
|
2022
Q2 | $3K | Hold |
|
|||||
|
2022
Q1 | $4K | Hold |
|
|||||
|
2021
Q4 | $7K | Hold |
|
|||||
|
2021
Q3 | $10K | Hold |
|
|||||
|
2021
Q2 | $8K | Hold |
|
|||||
|
2021
Q1 | $10K | Hold |
|
|||||
|
2020
Q4 | $10K | Sell |
|
|||||
|
2020
Q3 | $18K | Buy |
|
|||||
|
2020
Q2 | $20K | Hold |
|
|||||
|
2020
Q1 | $5K | Hold |
|
|||||
|
2019
Q4 | $2K | Buy |
|